344 shares
A person dressed as Lady Liberty wears a shirt with the letter Q, referring to QAnon, as protesters take part in a protest, Wednesday, Jan. 6, 2021, at the Capitol in Olympia, Wash., against the counting of electoral votes in Washington, DC, affirming President-elect Joe Biden s victory. (AP Photo/Ted S. Warren)
PROVIDENCE, Rhode Island (AP) Ceally Smith spent a year down the rabbit hole of QAnon, devoting more and more time to researching and discussing the conspiracy theory online. Eventually it consumed her, and she wanted out.
She broke up with the boyfriend who recruited her into the movement, took six months off social media, and turned to therapy and yoga.
COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says Sorry, but your browser needs Javascript to use this site. If you re not sure how to activate it, please refer to this site: https://www.enable-javascript.com/
A volunteer in Novavax’s South Africa trial is examined by a doctor before receiving an injection at Wits RHI Shandukani Research Centre, in Johannesburg, in December. | JOAO SILVA / THE NEW YORK TIMES
Reuters Jan 29, 2021
Chicago – Novavax Inc said Thursday its novel coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered in the country, according to a preliminary analysis.
Healthcare Leader Michael Rawlings Joins HSS
News provided by
Share this article
Share this article
NEW YORK, Jan. 29, 2021 /PRNewswire/ Healthcare executive Michael Rawlings has been appointed Senior Vice President of Facilities, Construction and Support Services by Hospital for Special Surgery (HSS). HSS is the world s leading academic medical center specialized in orthopedics, rheumatology, and related disciplines. In Orthopedics HSS ranked No. 1 in the world by Newsweek and No. 1 in the nation – 11 years in a row – by U.S. News & World Report.
Mr. Rawlings brings over 20 years of experience in healthcare and university research leadership and facilities management to HSS. Most recently, he was Chief Operating Officer at NYC Health + Hospitals/Bellevue. In that role, he was responsible for managing facility and support services, ancillary services, and behavioral health administration. Mr. Rawlings has led disaster management and emergency relief efforts after 9/11, Hur
Novavax vaccine 89 per cent effective in British trial
Julie Steenhuysen
Save
Share
Chicago | Novavax said on Thursday (Friday AEST) that its coronavirus vaccine was 89.3 per cent effective in preventing COVID-19 in a trial conducted in Britain, and was nearly as effective in protecting against the more highly contagious variant discovered there, according to a preliminary analysis.
A mid-stage trial of the vaccine in South Africa, where a troubling new variant of the virus is common, showed 60 per cent effectiveness among people who did not have HIV.
Novavax said the trial, which enrolled 15,000 people aged 18 to 84, was expected to be used to apply for regulatory review in Britain.Â